Because the begin of the COVID-19 pandemic, we’ve got identified that it might take unprecedented collaboration throughout a number of industries to sort out the virus. As we’ve got strived collectively to convey breakthrough science to the world, a continuing in our work has been collaborating with different organizations on options that streamline the affected person journey and simplify the methods through which folks study vaccines and therapy.
I used to be proud to focus on these efforts on behalf of Pfizer throughout a current panel dialogue on the international HLTH convention (October 8-11), which uniquely introduced collectively stakeholders from throughout the healthcare and expertise industries to collaborate on breakthrough options for sufferers.
We’re at an vital cut-off date in these efforts. The Facilities for Illness Management and Prevention (CDC) expects the 2023-2024 season will convey the same variety of whole hospitalizations from COVID-19, flu, and RSV as seen final yr.1 We should work to beat the challenges we face in getting folks info to allow them to make selections that assist shield themselves in opposition to COVID-19 and search care as early as potential in the event that they’ve been identified with COVID-19.2
All through the pandemic, we’ve been pioneering revolutionary methods to achieve sufferers who’ve acquired a analysis and meet them the place they’re with the data they should take subsequent steps. We all know that sufferers want their healthcare to be extra intuitive, linked, and accessible. Our objective is to assist simplify the method by partnering with those who already assist the affected person (similar to their well being supplier, pharmacy, or employer) and leveraging current platforms (like a well-known shopper setting or app on their telephone), in addition to by utterly new digital options.
For instance, by our partnership with Cue Health we offer details about the indicators, signs, and danger components for development to extreme COVID-19. Cue Care, a same-day, at-home, “take a look at to deal with” platform and the Cue Well being App are two examples of the assets this partnership gives.
By means of a partnership with Ada Health, we’re offering a digital, end-to-end COVID-19 care journey for sufferers. Customers start by taking a COVID-19 take a look at. Then, in three steps that every one happen in their very own dwelling, customers can fill out an eligibility questionnaire to be taught whether or not they might be in danger for development to extreme COVID-19, seek the advice of with a healthcare supplier by telemedicine, and, if eligible, obtain a prescription for therapy.
We’re proud not solely of how these partnerships, providers, and assets may help sufferers, but additionally how they might enhance well being fairness. By seamlessly connecting sufferers from underserved communities to therapy, we are able to probably scale back the whole value of care. These new pathways have additionally supplied us with approaches we are able to apply to different illness areas.
We’re all the time in search of methods to supply sufferers with what they should rapidly search therapy. Increasing our attain with exterior companions is important in our efforts and important in our mission to supply life-changing breakthroughs. I sit up for seeing the unbelievable enhancements in linked healthcare journeys that our future partnerships will proceed to make for sufferers.
By James Allen
Vice President, Check to Deal with and Partnerships, Pfizer
James is the International Strategic Partnerships Lead for the Antiviral & Diagnostics enterprise at Pfizer. He passionately believes within the alternative to remodel healthcare supply by cross-industry collaboration and studying the precise classes from disruptive innovation in adjoining sectors. In earlier roles, James led enterprise unit technique for Pfizer’s Oncology and Irritation and Immunology franchises, and has managed main customer-centered transformations throughout shopper items, monetary providers, authorities and retail organizations in addition to inside Healthcare and Life Sciences.
References
1. Respiratory illness season outlook. Facilities for Illness Management and Prevention. https://www.cdc.gov/forecast-outbreak-analytics/about/season-outlook.html. Final reviewed September 14, 2023. Accessed October 5, 2023.
2. Respiratory illness season outlook. Facilities for Illness Management and Prevention. https://www.cdc.gov/forecast-outbreak-analytics/about/season-outlook.html. Final reviewed September 14, 2023. Accessed October 5, 2023.
